Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T7535 |
RGX-202
胍基丙酸,β-GPA,3-Guanidinopropionic Acid |
AMPK; PPAR | Chromatin/Epigenetic; DNA Damage/DNA Repair; Metabolism; PI3K/Akt/mTOR signaling |
RGX-202 (β-GPA) 是口服有活性的SLC6A8转运蛋白抑制剂。它在体内外均能够强烈地抑制肌酸输入,降低细胞内磷酸肌酸和 ATP 水平,诱导肿瘤凋亡,可于研究肿瘤。 | |||
T5025L2 |
Pralmorelin HCl
WAY-GPA 748,WAY-GPA-748 WAY-GPA748,Pralmorelin dihydrochloride |
||
Pralmorelin HCl is regarded as a Growth Hormone Releasing Factor. | |||
T69827 |
GPA-1734 bromide
|
||
GPA-1734 bromide is an inhibitor of basement membrane collagen synthesis and angiogenesis. | |||
T83421 |
1-Palmitoyl-sn-glycerol 3-phosphate
1-P-GPA |
||
1-Palmitoyl-sn-glycerol 3-phosphate (1-P-GPA) 是内源性代谢物,常用于非酒精性脂肪性肝病的研究。 | |||
T70161 |
Berotralstat HCl
|
||
Berotralstat HCl is a novel selective inhibitor of plasma kallikrein, blocking the enzymatic activity of plasma kallikrein in releasing bradykinin, the major biologic peptide that promotes swelling and pain associated with attacks of HAE. | |||
T69826 |
U-0126
|
||
U0126 is a highly selective inhibitor of both MEK1 and MEK2, a type of MAPK/ERK kinase. It was found to functionally antagonize AP-1 transcriptional activity via noncompetitive inhibition of the dual specificity kinase MEK with IC50 of 72 nM for MEK1 and 58 nM for MEK2. U0126 inhibited anchorage-independent growth of Ki-ras-transformed rat fibroblasts by simultaneously blocking both extracellular signal-regulated kinase and mammalian target of rapamycin pathways. | |||
T70162 |
GPA512
|
||
GPA512 is a prodrug of aliellalactone, inhibiting STAT3 and preventing the transcription of STAT3 regulated genes. | |||
T82267 |
GPAT-IN-1
|
||
GPAT-IN-1为一种甘油3-磷酸酰基转移酶(GPAT)抑制剂,具有8.9 μM的IC50值,适用于肥胖症研究。 | |||
T83722 |
FALGPA TFA
2-Furanacryloyl-L-leucylglycyl-L-prolyl-L-alanine,2-Furanacryloyl-Leu-Gly-Pro-Ala-OH |
||
FALGPA是用于胶原蛋白酶的比色底物。它相对于胰蛋白酶、热蛋白酶和弹性蛋白酶具有选择性。胶原蛋白酶优先结合并切割Leu-Gly (LG) 肽序列以释放呋喃丙烯酰基团,该基团可通过在324至345 nm波长的比色检测被定量,作为衡量胶原蛋白酶活性的手段。FALGPA已被用于识别C. histolyticum胶原蛋白酶的抑制剂。 | |||
T10421 |
AVE5688
|
Phosphorylase | Metabolism |
AVE5688 是糖原磷酸化酶 (glycogen phosphorylase (GP)) 抑制剂,抑制兔肌肉糖原磷酸化酶 rmGPb 和 rmGPa 的活性,IC50 值分别为 430 nM 和 915 nM,Kd 值分别为 170 nM 和 530 nM;AVE5688 可用于二型糖尿病的研究。 | |||
T31048 |
CP-320626
CP 320626 |
||
CP-320626 is an effective inhibitor of glycogen phosphorylase A (LGPA) in the human liver and GPA in the human muscle. Can act synergistically with glucose. It is a possible target for the treatment of type 2 diabetes. |